ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för (R)-norketamine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

15 träffar

Bibliografisk träff 2024-06-21

Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine-But Not Esketamine-Induced Pain Relief.

Dahan A, Jansen S, van der Schrier R, Sarton E, Dadiomov D, van Velzen M, Olofsen E, Niesters M.

ACS Pharmacol Transl Sci · research-article; journal article · DOI 10.1021/acsptsci.4c00133

Bibliografisk träff 2024-03-27

Stereoselective Pharmacokinetics of Ketamine Administered at a Low Dose in Awake Dogs.

Pargätzi G, Bergadano A, Spadavecchia C, Theurillat R, Thormann W, Levionnois OL.

Animals (Basel) · research-article; journal article · DOI 10.3390/ani14071012

Bibliografisk träff 2023-10-10

Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist-induced behavioral disruptions in male and female mice.

Vinnakota C, Schroeder A, Du X, Ikeda K, Ide S, Mishina M, Hudson M, Jones NC, Sundram S, Hill RA.

J Neurosci Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1002/jnr.25257

Bibliografisk träff 2022-05-01

Ketamine Psychedelic and Antinociceptive Effects Are Connected.

Olofsen E, Kamp J, Henthorn TK, van Velzen M, Niesters M, Sarton E, Dahan A.

Anesthesiology · research support, non-u.s. gov't; journal article · DOI 10.1097/aln.0000000000004176

Bibliografisk träff 2021-07-15

Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged-Release Ketamine With Emphasis on 2,6-Hydroxynorketamines.

Weiss M, Siegmund W.

Clin Pharmacol Drug Dev · research support, non-u.s. gov't; journal article · DOI 10.1002/cpdd.993

Bibliografisk träff 2021-07-01

Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression.

Wang Y, Jiang R, Wu Z, Zhou L, Xu J, Huang C, Yang L, Zhu B, Yan E, Liu C, Yang C.

Pharmacol Biochem Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pbb.2021.173226

Bibliografisk träff 2020-02-20

(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.

Yokoyama R, Higuchi M, Tanabe W, Tsukada S, Naito M, Yamaguchi T, Chen L, Kasai A, Seiriki K, Nakazawa T, Nakagawa S, Hashimoto K, Hashimoto H, Ago Y.

Pharmacol Biochem Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pbb.2020.172876

Bibliografisk träff 2020-01-01

Online Enantioselective Capillary Electrophoretic Method for Screening Cytochrome P450 3A4 Inhibitors.

Řemínek R, Glatz Z, Thormann W.

Methods Mol Biol · research support, non-u.s. gov't; journal article · DOI 10.1007/978-1-0716-0163-1_11

Bibliografisk träff 2019-12-06

Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study.

Wang J, Huang J, Yang S, Cui C, Ye L, Wang SY, Yang GP, Pei Q.

Drug Des Devel Ther · comparative study; research-article; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.2147/dddt.s224553

Bibliografisk träff 2019-11-06

Pharmacokinetics of S-ketamine and R-ketamine and their active metabolites after racemic ketamine or S-ketamine intravenous administration in dogs sedated with medetomidine.

Romagnoli N, Bektas RN, Kutter APN, Barbarossa A, Roncada P, Hartnack S, Bettschart-Wolfensberger R.

Vet Anaesth Analg · randomized controlled trial, veterinary; journal article · DOI 10.1016/j.vaa.2019.08.048

Bibliografisk träff 2018-10-01

No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model.

Chang L, Toki H, Qu Y, Fujita Y, Mizuno-Yasuhira A, Yamaguchi JI, Chaki S, Hashimoto K.

Int J Neuropsychopharmacol · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1093/ijnp/pyy053

Bibliografisk träff 2018-05-14

AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.

Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K.

Biol Psychiatry · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.biopsych.2018.05.007

Bibliografisk träff 2018-05-03

(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.

Yamaguchi JI, Toki H, Qu Y, Yang C, Koike H, Hashimoto K, Mizuno-Yasuhira A, Chaki S.

Neuropsychopharmacology · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41386-018-0084-y

Bibliografisk träff 2018-01-01

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.

Shirayama Y, Hashimoto K.

Int J Neuropsychopharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1093/ijnp/pyx108

Bibliografisk träff 2009-03-19

NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.

Berger ML, Schweifer A, Rebernik P, Hammerschmidt F.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2009.03.025